Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks

被引：58

作者：

Diekmann, F

Campistol, JM

机构：

[1] Hosp Clin Barcelona, Dept Nephrol & Renal Transplantat, E-08036 Barcelona, Spain

[2] Univ Barcelona, IDIBAPS, E-08036 Barcelona, Spain

[3] Humboldt Univ, Dept Nephrol, Berlin, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷 / 03期

关键词：

chronic allograft nephropathy; conversion; cyclosporine A; proteinuria; sirolimus; tacrolimus;

D O I：

10.1093/ndt/gfi336

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：562 / 568

页数：7

共 36 条

[1] Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy [J].

Anglicheau, D ;

Le Corre, D ;

Lechaton, S ;

Laurent-Puig, P ;

Kreis, H ;

Beaune, P ;

Legendre, C ;

Thervet, E .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) :595-603

[2] Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus [J].

Bumbea, V ;

Kamar, N ;

Ribes, D ;

Esposito, L ;

Modesto, A ;

Guitard, J ;

Nasou, G ;

Durand, D ;

Rostaing, L .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (11) :2517-2523

[3]

del Castillo D., 1999, Journal of the American Society of Nephrology, V10, p726A

[4] Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction [J].

Diekmann, F ;

Budde, K ;

Oppenheimer, F ;

Fritsche, L ;

Neumayer, HH ;

Campistol, JM .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) :1869-1875

[5] Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy [J].

Dittrich, E ;

Schmaldienst, S ;

Soleiman, A ;

Hörl, WH ;

Pohanka, E .

TRANSPLANT INTERNATIONAL, 2004, 17 (04) :215-220

[6] Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience [J].

Dominguez, J ;

Mahalati, K ;

Kiberd, B ;

McAlister, VC ;

MacDonald, AS .

TRANSPLANTATION, 2000, 70 (08) :1244-1247

[7] Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up [J].

Ducloux, D ;

Motte, G ;

Billerey, C ;

Bresson-Vautrin, C ;

Vautrin, P ;

Rebibou, JM ;

Saint-Hillier, Y ;

Chalopin, JM .

TRANSPLANT INTERNATIONAL, 2002, 15 (08) :387-392

[8] Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study [J].

Dudley, C ;

Pohanka, E ;

Riad, H ;

Dedochova, J ;

Wijngaard, P ;

Sutter, C ;

Silva, HT .

TRANSPLANTATION, 2005, 79 (04) :466-475

[9] Conversion to sirolimus in solid organ transplantation: A single-center experience [J].

Egidi, MF ;

Cowan, PA ;

Naseer, A ;

Gaber, AO .

TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) :131S-137S

[10] Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies [J].

Fervenza, FC ;

Fitzpatrick, PM ;

Mertz, J ;

Erickson, SB ;

Liggett, S ;

Popham, S ;

Wochos, DN ;

Synhavsky, A ;

Hippler, S ;

Larson, TS ;

Bagniewski, SM ;

Velosa, JA .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1288-1292

← 1 2 3 4 →